SEARCH RESULT

Wednesday, May 31, 2023
Avivagen announces review of strategic alternatives
Avivagen recently announced the appointment of a special committee to review and assess strategic alternatives for the company to maximise stakeholder value going forward.
Friday, January 20, 2023
Avivagen announces scientific, commercial evidence of OxC-Beta published in peer-reviewed journal
Avivagen Inc. announced on January 19 that its scientific team has just published a peer-reviewed paper describing the discovery, natural occurrence, scientific significance, commercial livestock applications and safety of OxBC, the active ...
Thursday, August 11, 2022
Avivagen announces significant order of OxC-betaTMin Brazil
Avivagen Inc. announced recently that it has secured a significant order for OxC-beta™ from AB Vista.
Tuesday, June 14, 2022
Avivagen completes formal safety, toxicology evaluation of fully oxidised beta-carotene
Avivagen Inc. announced that it has completed a series of important safety evaluations of fully oxidised beta-carotene (OxBC), the proprietary and critical active ingredient in the company's highly-regarded OxC-betaTMproduct line.
Tuesday, February 22, 2022
Avivagen announces appointment of new president
Avivagen Inc. announced last month the appointment of James Nickerson, PhD as president of the company.
Tuesday, July 27, 2021
Avivagen announces strategic changes to support growth in Asia and South America
Avivagen Inc. has announced new strategic measures to support continued growth in Asia and Brazil.
Monday, May 31, 2021
Avivagen continues market growth with new client in Western Mexico
Avivagen Inc. announced this month that it has finalised an introductory order of its OxC-beta Livestock feed additive for use in Western Mexico.
Monday, May 31, 2021
Avivagen terminates exclusive US sales and distribution agreement
Avivagen Inc. announced early this month that it has terminated its sales and distribution agreement with CSA Animal Nutrition in the United States.
Tuesday, May 4, 2021
Avivagen announces largest single customer purchase order
Avivagen Inc. has announced on April 23 it has received a purchase order for a single shipment of 4.4 tonnes of OxC-beta Livestock from Philippines-based UNAHCO.
Tuesday, May 4, 2021
Avivagen announces first purchase order from integrated producer in Thailand
Avivagen Inc. has announced on April 26 it has received its first purchase order from a large, integrated livestock producer in Thailand.
Tuesday, May 4, 2021
Avivagen announces recurring order for OxC-beta Livestock
Avivagen Inc. has announced on May 3 that Meyenberg International Group, Avivagen's consultant in Mexico, has entered into a contract which secures a four tonnes per month recurring order for the company's OxC-beta Livestock in Mexico.
Monday, March 8, 2021
Upcoming research highlights benefits of Avivagen's OxC-betaTM Livestock for broilers
Avivagen Inc. has announced that a manuscript reporting the benefits of its OxC-betaTM Livestock feed additive for broiler poultry has been approved for publication by Poultry Science, a leading peer-reviewed journal.
Monday, February 8, 2021
Avivagen announces six-tonne order of OxC-beta Livestock from Mexico
Avivagen Inc. has announced last month that it has secured a six tonne order of its OxC-beta with Transformadora Agricola de Alimentos SA de CV in Mexico.
Tuesday, December 1, 2020
Avivagen announces expansion of non-dilutive financing in support of increased product sales
Avivagen Inc. has announced last month that, given the recent significant ramp up in placed orders for its OxC-beta Livestock™ and the upcoming launch of its human nutraceutical product, it has obtained additional debt financing of $350,000 ...
Tuesday, October 20, 2020
Avivagen announces non-dilutive financing in support of increased product sales
Avivagen Inc. announced on October 15 that it has obtained additional debt financing of $500,000 through an unsecured Promissory Note from a Canadian financial institution.

Follow Us

FacebookTwitterLinkedIn